Business Context and Reporting Period
This Form 8-K was filed by Reactive Medical Inc. (a Nevada corporation) on April 14, 2017. The report details a corporate name change approved by the Board of Directors and majority shareholders via written consent.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding a corporate action and does not contain financial statements.
Material Changes
- Name Change: The company filed a Certificate of Change with the Nevada Secretary of State to change its name from Reactive Medical Inc. to Artelo Biosciences, Inc.
- Effective Date: The name change is effective as of April 28, 2017.
- Regulatory Status: The company has submitted a notification to FINRA regarding the name change; approval is pending.
Outlook and Risks
Management indicated that a subsequent Form 8-K will be filed upon receipt of FINRA approval to announce the effectiveness of the name change and the company's new CUSIP number. No other risks, contingencies, or unusual items were disclosed in this filing.
Key Facts for Investors to Verify
- Confirmation of the new corporate name: Artelo Biosciences, Inc.
- The effective date of the name change: April 28, 2017.
- The status of FINRA approval for the name change and the issuance of a new CUSIP number.
- Future filings that will announce the new CUSIP number.